A previous study reports that blood-derived circulating tumor DNA markers, such as PIK3CA with frequent alteration, may be key biomarkers in diagnosis of advanced HCC and for HCC molecular diagnosis (35). This evidence concerns the gene PIK3CA and neoplasm.